Catalog NumberYM00173
CategoryADCs
Description
Mirvetuximab-MMAE is an ADC targeting FOLR1 (folate receptor 1). It can be used in ovarian and other FRα-positive cancer research.
Molecular Weight
1459.60
Purity
98% Min.
Storage
Store at -20°C
Endotoxin Levels
<1 EU/mg
Form
Powder
Formulation
100 mM Pro-Ac, 20 mM Arg, pH 5.0
Impurity Content
2% Max.
Protein Concentration
10.91 mg/mL
Size
1 mg